Nangibotide
Nangibotide is an inhibitor of TREM-1, a receptor found on certain white blood cells. Activation of TREM-1 stimulates inflammation. Nangibotide is therefore being investigated as a treatment for the overwhelming inflammation typically seen in severe sepsis.
Recent news mentioning Nangibotide
- — GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF
- — GENFIT engage un programme de développement clinique de phase 2 avec Nangibotide dans l’ACLF